2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetonitrile; (1,1,3-trioxo-1,3-dihydro-1LAMBDA6-benzo[D]isothiazol-2-yl)-acetonitrile; CHEMBL3125559; (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetonitrile; 2-(1,1,3-trioxo-2,3-dihydro-1H-1lambda~6~-benzo[d]isothiazol-2-yl)acetonitrile; C9H6N2O3S; NSC45113; N-cyanomethylsaccharin; Maybridge1_001405; (1,1,3-Trioxo-1,3-dihydro-1lambda*6*-benzo[d]isothiazol-2-yl)-acetonitrile; Cambridge id 5230983; Oprea1_044316; Oprea1_752022; SCHEMBL9830407; CTK4J5552; HMS545H19; ZINC50251; DTXSID50286377; BBL008430; BDBM50496463; HTS001015; MFCD00117404; NSC-45113; STK788557; AKOS000122471; BL-0037; BS-4305; MCULE-9448122073; SDCCGMLS-0065857.P001; KS-0000230T; FT-0608350; H2763; ST50267624; Y9325; 2-Cyanomethyl-benzisothiazolinone-1,1-dioxide; EN300-05858; SR-01000509918; J-505282; SR-01000509918-1; 2-Cyanomethyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide; 2-(1,1,3-trioxo-2-hydrobenzo[d]isothiazol-2-yl)ethanenitrile; 2-(1,1-Dioxido-3-oxobenzo[d]isothiazol-2(3H)-yl)acetonitrile; (1,1-Dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)acetonitrile #; 2-(1,1,3-trioxo-2,3-dihydro-1,2-benzothiazol-2-yl)acetonitrile; (1,1,3-Trioxo-1,3-dihydro-2H-1lambda~6~,2-benzothiazol-2-yl)acetonitrile; 2-(1,1,3-Trioxo-2,3-dihydro-1H-benzo[d]isothiazol-2-yl)acetonitrile; 2-(1,1,3-trioxo-2,3-dihydro-1lambda6,2-benzothiazol-2-yl)acetonitrile